Plc Glaxosmithkline - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Bicycle Therapeutics PLC (BCYC). Other recent insider transactions involving Bicycle Therapeutics PLC (BCYC) include a net sale of 11,929 shares made by Travis Alvin Thompson , a net sale of 32,824 shares made by Kevin Lee , and a net sale of 12,694 shares made by Alistair Milnes .

In summary, during the past 3 months, insiders sold 10,599 shares of Bicycle Therapeutics PLC (BCYC) in total and bought 0 shares, with a net sale of 10,599 shares. During the past 18 months, 87,269 shares of Bicycle Therapeutics PLC (BCYC) were sold and 1,485,397 shares were bought by its insiders, resulting in a net purchase of 1,398,128 shares.

Bicycle Therapeutics PLC (BCYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 20,938 shares made by Paul J Hastings , a net sale of 13,707 shares made by Alicia J. Hager , and a net sale of 9,094 shares made by David Shook .

In summary, during the past 3 months, insiders sold 1,790 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 1,790 shares. During the past 18 months, 61,852 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,938,148 shares.

Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Theravance Biopharma Inc (TBPH). Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include a net sale of 51,254 shares made by Rhonda Farnum , and a net purchase of 2,498,924 shares made by Eli Samaha .

In summary, during the past 3 months, insiders sold 34,000 shares of Theravance Biopharma Inc (TBPH) in total and bought 0 shares, with a net sale of 34,000 shares. During the past 18 months, 51,254 shares of Theravance Biopharma Inc (TBPH) were sold and 2,498,924 shares were bought by its insiders, resulting in a net purchase of 2,447,670 shares.

Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Turning Point Therapeutics Inc (TPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turning Point Therapeutics Inc (TPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Turning Point Therapeutics Inc (TPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Progyny Inc (PGNY). Other recent insider transactions involving Progyny Inc (PGNY) include a net sale of 11,000 shares made by David J Schlanger , a net sale of 28,595 shares made by Michael E Sturmer , and a net sale of 36,426 shares made by Mark S. Livingston .

In summary, during the past 3 months, insiders sold 2,675 shares of Progyny Inc (PGNY) in total and bought 0 shares, with a net sale of 2,675 shares. During the past 18 months, 230,158 shares of Progyny Inc (PGNY) were sold and 359,500 shares were bought by its insiders, resulting in a net purchase of 129,342 shares.

Progyny Inc (PGNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Orchard Therapeutics PLC (ORTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orchard Therapeutics PLC (ORTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Orchard Therapeutics PLC (ORTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,618 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .

In summary, during the past 3 months, insiders sold 498 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 498 shares. During the past 18 months, 5,618 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 37,742 shares.

Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Morphic Holding Inc (MORF). Other recent insider transactions involving Morphic Holding Inc (MORF) include a net sale of 43,936 shares made by Marc Schegerin , a net sale of 30,272 shares made by Farrell Robert E Jr , and a net sale of 21,582 shares made by Praveen P. Tipirneni .

In summary, during the past 3 months, insiders sold 0 shares of Morphic Holding Inc (MORF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 125,790 shares of Morphic Holding Inc (MORF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 125,790 shares.

Morphic Holding Inc (MORF)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of ChemoCentryx Inc (CCXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChemoCentryx Inc (CCXI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ChemoCentryx Inc (CCXI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Liquidia Corp (LQDA). Other recent insider transactions involving Liquidia Corp (LQDA) include a net sale of 26,898 shares made by Jason Adair , a net sale of 46,615 shares made by Rajeev Saggar , and a net sale of 36,734 shares made by Scott Moomaw .

In summary, during the past 3 months, insiders sold 151,452 shares of Liquidia Corp (LQDA) in total and bought 0 shares, with a net sale of 151,452 shares. During the past 18 months, 567,315 shares of Liquidia Corp (LQDA) were sold and 487,078 shares were bought by its insiders, resulting in a net sale of 80,237 shares.

Liquidia Corp (LQDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Spero Therapeutics Inc (SPRO). Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 266,525 shares made by Sath Shukla , a net sale of 138,926 shares made by Ankit Mahadevia , and a net sale of 89,721 shares made by Timothy Keutzer .

In summary, during the past 3 months, insiders sold 0 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 615,438 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 615,438 shares.

Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Translate Bio Inc (TBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Translate Bio Inc (TBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Translate Bio Inc (TBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Rein Therapeutics Inc (RNTX). Other recent insider transactions involving Rein Therapeutics Inc (RNTX) include a net sale of 95,059 shares made by , and a net purchase of 400 shares made by James Brian Windsor .

In summary, during the past 3 months, insiders sold 0 shares of Rein Therapeutics Inc (RNTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 95,059 shares of Rein Therapeutics Inc (RNTX) were sold and 400 shares were bought by its insiders, resulting in a net sale of 94,659 shares.

Rein Therapeutics Inc (RNTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of HTG Molecular Diagnostics Inc (HTGMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HTG Molecular Diagnostics Inc (HTGMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

HTG Molecular Diagnostics Inc (HTGMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 241,024 shares made by Samarth Kulkarni , a net sale of 25,642 shares made by James R. Kasinger , and a net sale of 3,932 shares made by .

In summary, during the past 3 months, insiders sold 3,932 shares of CRISPR Therapeutics AG (CRSP) in total and bought 989,812 shares, with a net purchase of 985,880 shares. During the past 18 months, 286,882 shares of CRISPR Therapeutics AG (CRSP) were sold and 996,812 shares were bought by its insiders, resulting in a net purchase of 709,930 shares.

CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Innoviva Inc (INVA). Other recent insider transactions involving Innoviva Inc (INVA) include a net sale of 1,618,295 shares made by Alexander J Denner ,

In summary, during the past 3 months, insiders sold 0 shares of Innoviva Inc (INVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,618,295 shares of Innoviva Inc (INVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,618,295 shares.

Innoviva Inc (INVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Applied Genetic Technologies Corp (AGTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Applied Genetic Technologies Corp (AGTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Applied Genetic Technologies Corp (AGTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 111,634 shares made by Bradley L Campbell , a net sale of 92,409 shares made by John F Crowley , and a net sale of 30,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 0 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 253,470 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 253,470 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of OncoMed Pharmaceuticals Inc (OMED) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of OncoMed Pharmaceuticals Inc (OMED) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

OncoMed Pharmaceuticals Inc (OMED)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Response Genetics Inc (RGDXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Response Genetics Inc (RGDXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Response Genetics Inc (RGDXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Quest Diagnostics Inc (DGX). Other recent insider transactions involving Quest Diagnostics Inc (DGX) include a net sale of 80,336 shares made by Michael E Prevoznik , a net sale of 49,012 shares made by Catherine T. Doherty , and a net sale of 8,080 shares made by Karthik Kuppusamy .

In summary, during the past 3 months, insiders sold 1,748 shares of Quest Diagnostics Inc (DGX) in total and bought 0 shares, with a net sale of 1,748 shares. During the past 18 months, 202,015 shares of Quest Diagnostics Inc (DGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 202,015 shares.

Quest Diagnostics Inc (DGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Anacor Pharmaceuticals Inc (ANAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anacor Pharmaceuticals Inc (ANAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anacor Pharmaceuticals Inc (ANAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in CVRx Inc (CVRX). Other recent insider transactions involving CVRx Inc (CVRX) include a net purchase of 8,500 shares made by Joseph P Slattery , a net purchase of 198,779 shares made by Kirk G. Nielsen , and a net purchase of 35,000 shares made by Kevin Hykes .

In summary, during the past 3 months, insiders sold 0 shares of CVRx Inc (CVRX) in total and bought 205,429 shares, with a net purchase of 205,429 shares. During the past 18 months, 7,700 shares of CVRx Inc (CVRX) were sold and 243,929 shares were bought by its insiders, resulting in a net purchase of 236,229 shares.

CVRx Inc (CVRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Decibel Therapeutics Inc (DBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Decibel Therapeutics Inc (DBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Decibel Therapeutics Inc (DBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Lyell Immunopharma Inc (LYEL). Other recent insider transactions involving Lyell Immunopharma Inc (LYEL) include a net purchase of 200,000 shares made by Charles W. Newton , a net purchase of 200,000 shares made by Sumant Ramachandra , and a net purchase of 175,000 shares made by Lynn Seely .

In summary, during the past 3 months, insiders sold 0 shares of Lyell Immunopharma Inc (LYEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyell Immunopharma Inc (LYEL) were sold and 36,650 shares were bought by its insiders, resulting in a net purchase of 36,650 shares.

Lyell Immunopharma Inc (LYEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in 23andMe Holding Co (MEHCQ). Other recent insider transactions involving 23andMe Holding Co (MEHCQ) include a net sale of 308,387 shares made by Kathy L Hibbs ,

In summary, during the past 3 months, insiders sold 0 shares of 23andMe Holding Co (MEHCQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,419 shares of 23andMe Holding Co (MEHCQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 15,419 shares.

23andMe Holding Co (MEHCQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made 1 insider transaction in WAVE Life Sciences Ltd (WVE) with a net purchase of 2,791,930. Other recent insider transactions involving WAVE Life Sciences Ltd (WVE) include a net sale of 409,099 shares made by Paul Bolno , a net sale of 244,836 shares made by Chris Francis , and a net sale of 32,776 shares made by Kyle Moran .

In summary, during the past 3 months, insiders sold 30,000 shares of WAVE Life Sciences Ltd (WVE) in total and bought 0 shares, with a net sale of 30,000 shares. During the past 18 months, 727,211 shares of WAVE Life Sciences Ltd (WVE) were sold and 2,791,930 shares were bought by its insiders, resulting in a net purchase of 2,064,719 shares.

WAVE Life Sciences Ltd (WVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GGNNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GGNNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GGNNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.